Rayner Surgical Drug Patent Portfolio
Rayner Surgical owns 1 orange book drug protected by 13 US patents Given below is the list of Rayner Surgical's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9066856 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | 23 Apr, 2034 | Active |
| US9486406 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | 23 Apr, 2034 | Active |
| US9066856 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | 23 Oct, 2033 | Active |
| US9486406 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | 23 Oct, 2033 | Active |
| US9855246 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | 23 Oct, 2033 | Active |
| US8173707 | Ophthalmologic irrigation solutions and method | 30 Jan, 2024 | Expired |
| US8586633 | Ophthalmologic irrigation solutions and method | 30 Jan, 2024 | Expired |
| US9278101 | Ophthalmologic irrigation solutions and method | 30 Jan, 2024 | Expired |
| US9399040 | Ophthalmologic irrigation solutions and method | 30 Jan, 2024 | Expired |
| US8173707 | Ophthalmologic irrigation solutions and method | 30 Jul, 2023 | Expired |
| US8586633 | Ophthalmologic irrigation solutions and method | 30 Jul, 2023 | Expired |
| US9278101 | Ophthalmologic irrigation solutions and method | 30 Jul, 2023 | Expired |
| US9399040 | Ophthalmologic irrigation solutions and method | 30 Jul, 2023 | Expired |
Latest Legal Activities on Rayner Surgical's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rayner Surgical.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 10 Jun, 2024 | US8173707 (Litigated) |
|
Email Notification
Critical
| 22 May, 2024 | US9486406 |
|
Email Notification
Critical
| 22 May, 2024 | US9855246 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 22 May, 2024 | US9855246 |
|
Email Notification
Critical
| 22 May, 2024 | US9066856 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 22 May, 2024 | US9066856 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 22 May, 2024 | US9486406 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 10 Apr, 2024 | US9486406 |
|
Email Notification
Critical
| 10 Apr, 2024 | US9486406 |
|
Maintenance Fee Reminder Mailed
Critical
| 18 Mar, 2024 | US9399040 |
|
Maintenance Fee Reminder Mailed
Critical
| 25 Dec, 2023 | US8173707 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 30 Oct, 2023 | US9278101 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Nov, 2022 | US9066856 (Litigated) |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 02 Jul, 2021 | US9855246 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 19 May, 2021 | US8586633 (Litigated) |
Rayner Surgical's Family Patents
Rayner Surgical drugs have patent protection in a total of 39 countries. It's US patent count contributes only to 30.7% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Rayner Surgical Drug List
Given below is the complete list of Rayner Surgical's drugs and the patents protecting them.
1. Omidria
Omidria is protected by 13 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9066856
(Pediatric)
| Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
23 Apr, 2034
(9 years from now)
| Active |
| US9486406
(Pediatric)
| Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
23 Apr, 2034
(9 years from now)
| Active |
| US9066856 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
23 Oct, 2033
(8 years from now)
| Active |
| US9486406 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
23 Oct, 2033
(8 years from now)
| Active |
| US9855246 | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
23 Oct, 2033
(8 years from now)
| Active |
| US8173707
(Pediatric)
| Ophthalmologic irrigation solutions and method |
30 Jan, 2024
(1 year, 24 days ago)
| Expired |
| US8586633
(Pediatric)
| Ophthalmologic irrigation solutions and method |
30 Jan, 2024
(1 year, 24 days ago)
| Expired |
| US9278101
(Pediatric)
| Ophthalmologic irrigation solutions and method |
30 Jan, 2024
(1 year, 24 days ago)
| Expired |
| US9399040
(Pediatric)
| Ophthalmologic irrigation solutions and method |
30 Jan, 2024
(1 year, 24 days ago)
| Expired |
| US8173707 | Ophthalmologic irrigation solutions and method |
30 Jul, 2023
(1 year, 6 months ago)
| Expired |
| US8586633 | Ophthalmologic irrigation solutions and method |
30 Jul, 2023
(1 year, 6 months ago)
| Expired |
| US9278101 | Ophthalmologic irrigation solutions and method |
30 Jul, 2023
(1 year, 6 months ago)
| Expired |
| US9399040 | Ophthalmologic irrigation solutions and method |
30 Jul, 2023
(1 year, 6 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omidria's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List